SAMSUNG PHARM. Co., LTD. (KRX: 001360)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,540.00
-53.00 (-3.33%)
Dec 20, 2024, 3:30 PM KST

SAMSUNG PHARM. Co., LTD. Statistics

Total Valuation

SAMSUNG PHARM. Co., LTD. has a market cap or net worth of KRW 144.95 billion.

Market Cap 144.95B
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

SAMSUNG PHARM. Co., LTD. has 94.12 million shares outstanding.

Current Share Class n/a
Shares Outstanding 94.12M
Shares Change (YoY) n/a
Shares Change (QoQ) -6.93%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 4.63%
Float 84.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.02
PB Ratio 0.67
P/TBV Ratio 1.08
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.11.

Current Ratio 2.38
Quick Ratio 1.38
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF -0.97
Interest Coverage -11.20

Financial Efficiency

Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -3.60%.

Return on Equity (ROE) -4.40%
Return on Assets (ROA) -3.34%
Return on Capital (ROIC) -3.60%
Revenue Per Employee 186.06M
Profits Per Employee -24.83M
Employee Count 240
Asset Turnover 0.27
Inventory Turnover 2.89

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.77% in the last 52 weeks. The beta is 0.93, so SAMSUNG PHARM. Co., LTD.'s price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change -22.77%
50-Day Moving Average 1,589.48
200-Day Moving Average 1,654.60
Relative Strength Index (RSI) 48.18
Average Volume (20 Days) 428,119

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SAMSUNG PHARM. Co., LTD. had revenue of KRW 44.65 billion and -5.96 billion in losses. Loss per share was -101.96.

Revenue 44.65B
Gross Profit 8.02B
Operating Income -8.77B
Pretax Income -5.90B
Net Income -5.96B
EBITDA -4.67B
EBIT -8.77B
Loss Per Share -101.96
Full Income Statement

Balance Sheet

The company has 11.22 billion in cash and 14.28 billion in debt, giving a net cash position of -3.06 billion or -32.53 per share.

Cash & Cash Equivalents 11.22B
Total Debt 14.28B
Net Cash -3.06B
Net Cash Per Share -32.53
Equity (Book Value) 134.01B
Book Value Per Share 2,288.01
Working Capital 30.30B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.42 billion and capital expenditures -8.31 billion, giving a free cash flow of -14.73 billion.

Operating Cash Flow -6.42B
Capital Expenditures -8.31B
Free Cash Flow -14.73B
FCF Per Share -156.47
Full Cash Flow Statement

Margins

Gross margin is 17.96%, with operating and profit margins of -19.63% and -13.34%.

Gross Margin 17.96%
Operating Margin -19.63%
Pretax Margin -13.21%
Profit Margin -13.34%
EBITDA Margin -10.47%
EBIT Margin -19.63%
FCF Margin n/a

Dividends & Yields

SAMSUNG PHARM. Co., LTD. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.91%
Shareholder Yield -24.91%
Earnings Yield -6.62%
FCF Yield -10.16%

Stock Splits

The last stock split was on April 26, 1995. It was a forward split with a ratio of 1.1.

Last Split Date Apr 26, 1995
Split Type Forward
Split Ratio 1.1

Scores

SAMSUNG PHARM. Co., LTD. has an Altman Z-Score of 4.08.

Altman Z-Score 4.08
Piotroski F-Score n/a